MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-KL-07-0004842
Preemptive Meds Private Limited
Preemptive Meds Private Limited - business services in Kottayam, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2020
₹80.41 Lakh
▲ 860% YoY
Net profit · FY 2020
₹4.26 Lakh
Net margin 5.3%
EBITDA · FY 2020
₹35.81 Lakh
EBITDA margin 44.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Satisfied charges
₹12 Lakh
No open charges
Company age
15 yrs
Est. 2011
Directors on board
3
As per MCA filings
About Preemptive Meds Private Limited
Data last updated:
Preemptive Meds Private Limited is a private limited company based in Kottayam, Kerala, India. It operates in the csw professional segment of the business services sector. It was incorporated on 30 September 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24100KL2011PTC029481. Its GSTIN is 32AAGCP7295M1ZU (Kerala). The company holds 4 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including George Fenn and Jessy Fenn George.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thoppil House Vazhoor Post, Kottayam, Kerala, India – 686504.
As per the financials filed for FY 2020, the company reported a revenue of ₹80.41 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹4.26 Lakh (net margin 5.3%) and EBITDA of ₹35.81 Lakh (EBITDA margin 44.5%). Revenue has grown at a compounded annual rate (CAGR) of 37% over three years.
As per MCA filings, the company has satisfied charges of ₹12 Lakh on record. The company has 1 deal on record (1 secondary share transfer); the latest was in May 2019.
Preemptive Meds Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-07-0004842). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24100KL2011PTC029481
Registration Number 029481
Incorporation Date 30 September 2011
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KL-07-0004842
CIN history
Preemptive Meds has one previous CIN (Corporate Identification Number): U51397KL2011PTC029481. The current CIN is U24100KL2011PTC029481, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100KL2011PTC029481 | Current |
| U51397KL2011PTC029481 | Previous |
Recognitions & Rankings of Preemptive Meds
Contact details
Preemptive Meds Private Limited's registered office is in Kottayam, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressThoppil House Vazhoor Post, Kottayam, Kerala, India – 686504
- IndustryBusiness Services, Csw Professional, Scientific And Technical Activities
To see the full contact details of Preemptive Meds Private Limited, buy the company report.
Comprehensive company report
Preemptive Meds Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Preemptive Meds Private Limited
FY 2025 filings availablePreemptive Meds Private Limited reported revenue of ₹80.41 Lakh (up 860% YoY) for FY 2020.
Revenue · FY 2020
₹80.41 Lakh ▲ 860%
Net profit · FY 2020
₹4.26 Lakh margin 5.3%
EBITDA · FY 2020
₹35.81 Lakh margin 44.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 860%
3 years · compounded
▲ 37%
EBITDA CAGR growth
3 years · compounded
▲ 38%
Revenue has grown at a compounded annual rate (CAGR) of 37% over three years, including 860% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹80.41 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹35.81 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.26 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 44.5% | ||||
| Net Profit Margin | 5.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Preemptive Meds Private Limited, buy the company report.
Board of directors of Preemptive Meds Private Limited
Preemptive Meds has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| George Fenn Also directs: NCD Predisease Forum | Director | 30 Sep 2011 | 15 Years 0 Months | Current |
| Jessy Fenn George Also directs: Pfoods Private Limited | Director | 30 Sep 2011 | 15 Years 0 Months | Current |
| Joe George Fenn Also directs: Pfoods Private Limited | Director | 02 Dec 2019 | 6 Years 10 Months | Current |
Auditor
Preemptive Meds Private Limited is audited by SAJU C KURUVILLA for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SAJU C KURUVILLA | FY 2017 | 202601 |
Shareholding
The shareholding of Preemptive Meds Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Preemptive Meds Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹12 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Nov 2019 | 100302611 | Others | ₹12 Lakh | Satisfied |
To see the full charge records of Preemptive Meds Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Preemptive Meds Private Limited has 1 deal on record (1 secondary share transfer); the latest was in May 2019.
Total deals
1
Secondary share transfer
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Preemptive Meds Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Preemptive Meds Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Preemptive Meds has 4 GST registrations: 3 active and 1 cancelled or inactive.
Total GSTINs
4
Active
3
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAGCP7295M1ZU | Kerala | Active | 01 Jul 2017 |
| 07AAGCP7295M1ZN | Delhi | Active | 19 Dec 2019 |
| 29AAGCP7295M1ZH | Karnataka | Active | 08 May 2021 |
To see the full GST registrations and return filing status of Preemptive Meds Private Limited, buy the company report.
Recent activity
Preemptive Meds Private Limited has 4 board changes on record since 2011: 3 appointments and 1 cessation. The latest: Joe George Fenn ceased to be Additional Director on 30 Dec 2020.
AGM
Preemptive Meds Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Preemptive Meds Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Charges
A charge registered on 07 Nov 2019 via Charge ID 100302611 with Others was fully satisfied on 18 Apr 2024.
Ceased
Joe George Fenn ceased to be Additional Director.
Appointed
Joe George Fenn was appointed as Director.
Charges
A charge with Others amounted to Rs. 12.00 Lakh with Charge ID 100302611 was registered on 07 Nov 2019.
Appointed
George Fenn was appointed as Director.
Appointed
Jessy Fenn George was appointed as Director.
Incorporation
30 Sep 2011
Preemptive Meds Private Limited was registered on 30 Sep 2011 with Roc Ernakulam & aged 15 years 24 days as per MCA records.
Frequently asked questions
Preemptive Meds is an active private limited company based in Kottayam, Kerala, India. The company works in csw professional, within the business services industry. It was incorporated on 30 September 2011 (15+ years old) and is registered under CIN U24100KL2011PTC029481.
Preemptive Meds has 3 current directors:
- George Fenn - Director
- Jessy Fenn George - Director
- Joe George Fenn - Director
The latest financial statements of Preemptive Meds on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Preemptive Meds is 32AAGCP7295M1ZU, registered in Kerala. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 07AAGCP7295M1ZN (Delhi), 29AAGCP7295M1ZH (Karnataka).
The CIN (Corporate Identification Number) of Preemptive Meds is U24100KL2011PTC029481. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Preemptive Meds was incorporated on 30 September 2011, making it 15+ years old. It is registered with the Registrar of Companies, Ernakulam.
Preemptive Meds has 1 deal on record (1 secondary share transfer); the latest was in May 2019.
Joe George Fenn ceased to be Additional Director on 30 Dec 2020. Joe George Fenn was appointed as Director on 02 Dec 2019. George Fenn was appointed as Director on 30 Sep 2011. Preemptive Meds has 4 board changes on record in total.
Yes, Preemptive Meds is registered as a micro enterprise under Udyam registration (number: UDYAM-KL-07-0004842).
The registered office of Preemptive Meds is at Thoppil House Vazhoor Post, Kottayam, Kerala, India – 686504.